Koronavirüs Hastalığı’nın Yetişkinlerin Beslenme ve Fiziksel Aktivite Durumuna Etkisi; COVID-19 ve Beslenme

Amaç: Bu araştırma Yeni Koronavirüs Hastalığı’ndan (COVID-19) önce ve hastalık döneminde yetişkin bireylerinbeslenme ve fiziksel aktivite durumlarını değerlendirmek amacıyla planlanmıştır.Gereç ve Yöntemler: Karşılaştırmalı ve tanımlayıcı tipteki bu araştırmaya yaşları 20-65 yaş arasında olan 579 yetişkinbirey katılmıştır. Yeni tip koronavirüsün solunum ve damlacık yoluyla bulaşmaktadır. Bu nedenle virüsten korunmakamacıyla anket yüz yüze yapılmayıp, elektronik ortamda gönüllü katılımcılara ulaştırılmıştır. Araştırmada COVID-19pandemisinden önce ve pandemi dönemindeki beslenme alışkanlıkları ve fiziksel aktivite durumunu karşılaştırmakamacıyla bağımlı gruplarda t testi, McNemar ve McNemar-Bowker testleri kullanılmıştır.Bulgular: Yaş ortalaması 30,8 ±8,9 yıl olan bireylerin, COVID-19’dan korunmak için en çok tercih ettikleri vitaminin Dvitamini (%44,3) ve en çok tercih ettikleri mineralin ise çinko (%21,4) olduğu tespit edilmiştir. Bireylerin pandemidöneminde pandemi öncesine göre öğle öğününü daha çok atladıkları saptanmıştır (p

The Effect of Coronavirus Disease on Nutrition and Physical Activity Status of Adults; COVID-19 and Nutrition

Aim: This research was planned to evaluate the nutritional and physical activity status of adult individuals before and during the coronavirus disease (COVID-19). Material and Methods: 579 adult individuals aged 20-65 years participated in this descriptive and comparative study. The novel coronavirus is transmitted through respiration and droplet. For this reason, the questionnaire was not made face-to-face in order to protect against the virus and was sent to volunteers in electronic environment. In the study, McNemar test, McNemar-Bowker test and Paired sample t test were used to compare the nutritional habits and physical activity status before the COVID-19 pandemic and during the pandemic period. Results: It was determined that the individuals with the average age of 30.8 ± 8.9 years were the most preferred vitamin D (44.3%) and the most preferred mineral was zinc (21.4%) for protection from COVID-19. It was found that individuals skipped lunch more than during the pandemic period (p

PDF

___

1. World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 [Internet]. Geneva, Switzerland: World Health Organization; c2015-07 [Updated: 2020 Jun 17; Cited:.2020 Apr 18]...Available from: https://www.who.int/publications/m/item/summaryof-probable-sars-cases-with-onset-of-illness-from-1- november-2002-to-31-july-2003
2. World Health Organization. WHO MERS-CoV Global summary and assessment of risk, august 2018 (who/mers/ra/august18) [Internet]. Geneva, Switzerland: World Health Organization; c2018-08 [Updated: 2020 Jun 17; Cited:.2020 Apr 18]. Available from: https://www.who.int/csr/disease/coronavirus_infectio ns/risk-assessment-august 2018.pdf?ua=1.
3. Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding. Lancet. 2020; 395: 565–74.
4. World Health Organization. Coronavirus disease (COVID-19) situation dashboard [Internet]. Geneva, Switzerland: World Health Organization; c2020-06 [Updated: 2020 Jun 18; Cited: 2020 Apr 19]. Available from: https://covid19.who.int/.
5. Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020; 92(4): 418-23.
6. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020; 382(8): 727- 33.
7. Arabi YM, Fowler R, Hayden FG. Critical care management of adults with community-acquired severe respiratory viral infection. Intensive Care Medicine. 2020; 46(2): 315-28.
8. Cintoni M, Rinninella E, Annetta MG, Mele MC. Nutritional management in hospital setting during SARS-CoV-2 pandemic: a real-life experience. Eur. J. Clin. Nutr. 2020; 74(5): 846-7.
9. Naicker S, Yang CW, Hwang SJ, Liu BC, Chen JH, Jha V. The Novel Coronavirus 2019 epidemic and kidneys. Kidney Int. 2020; 97(5): 824-8.
10. Lawton G. You're only as young as your immune system. New Scientist. 2020; 245(3275): 44-8.
11. Saul AW. Nutritional treatment of coronavirus. Orthomolecular Medicine News Service. 2020; 16(6): 22.
12. Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol. 2020; 92(5): 479-90.
13. T.C. Sağlık Bakanlığı. Yeni koronavirüs riskine karşı 14 kural [Internet]. Ankara, Türkiye: T.C. Sağlık Bakanlığı; c2020-06 [Son güncelleme tarihi: 18 Haziran 2020; Erişim tarihi: 19 Nisan 2020]. Erişim adresi: https://covid19bilgi.saglik.gov.tr/tr/afis.html.
14. Stipp MM. SARS-CoV-2: Micronutrient optimization in supporting host ımmunocompetence. Int J Clin Case Rep Rev. 2020; 2(2): 24.
15. Bajwa SJS, Sarna R, Bawa C, Mehdiratta L. Perioperative and critical care concerns in coronavirus pandemic. Indian J. Anaesth. 2020; 64(4): 267.
16. Chen P, Mao L, Nassis GP, Harmer P, Ainsworth BE, Li F. Wuhan coronavirus (2019-nCoV): The need to maintain regular physical activity while taking precautions. J Sport Health Sci. 2020; 9(2): 103.
17. Yorulmaz M. Çalışan Algısına Göre Gemi Performansı Ölçeğinin Geliştirilmesi: Geçerlilik Ve Güvenilirlik Çalışması. Avrasya Uluslararası Araştırmalar Dergisi. 2019; 7(16): 1053-65.
18. Food and Drug Administration. Coronavirus (COVID-19) Update: FDA Continues to Accelerate Development of Novel Therapies for COVID-19 [Internet]. United States: c2020-03 [Updated: 2020 Jun 18; Cited: 2020 Jun 6]. Available from: https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fdacontinues-accelerate-development-novel-therapiescovid-19.
19. European Medicines Agency. Treatments and vaccines for COVID-19 [Internet]. Amsterdam, Netherlands: c2020-04 [Updated: 2020 Jun 18; Cited: 2020 Jun 6]. Available from:.https://www.ema.europa.eu/en/humanregulatory/overview/public-healththreats/coronavirus-disease-covid-19/treatmentsvaccines-covid-19.
20. Kandeel M, Al-Nazawi M. Virtual screening and repurposing of FDA approved drugs against COVID19 main protease. Life Sci. 2020; 117627.
21. Khodadadi E, Maroufi P, Khodadadi E, Esposito I, Ganbarov K, Espsoito S, et al. Study of combining virtual screening and antiviral treatments of the SarsCoV-2 (Covid-19). Microb Pathog. 2020; 104241.
22. Panarese A, Shahini E. Covid‐ 19, and vitamin D. Aliment Pharmacol Ther. 2020; 51(10): 993.
23. Chakhtoura M, Napoli N, Fuleihan GEH. Myths and Facts on vitamin D amidst the COVID-19 pandemic. Metabolism. 2020; 109: 154276.
24. Kumar A, Kubota Y, Chernov M, Kasuya H. Potential role of zinc supplementation in prophylaxis and treatment of COVID-19. Med Hypotheses. 2020; 109848.
25.Johnstone J, Roth DE, Guyatt G, Loeb M. Zinc for the treatment of the common cold: a systematic review and meta-analysis of randomized controlled trials. CMAJ. 2012; 184(10): E551-61.
26. Adams KK, Baker WL, Sobieraj DM. Busters: Dietary Supplements and COVID-19. Ann Pharmacother. 2020; 1-7.
27. Derwand R, Scholz M. Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win todays battle against COVID-19?. Med Hypotheses. 2020; 142: 109815.
28. Young TK, Zampella JG. Supplements for COVID19: A modifiable environmental risk. Clin Immunol. 2020; 216: 108465.
29. Elmowalid GA, El-Hamid MIA, El-Wahab AMA, Atta M, El-Naser GA, Attia AM. Garlic and ginger extracts modulated broiler chicks innate immune responses and enhanced multidrug resistant Escherichia coli O78 clearance. Comp Immunol Microbiol Infect Dis. 2019; 66: 101334.
30. Yoshida Y, Wang MQ, Liu JN, Shan BE, Yamashita, U. Immunomodulating activity of Chinese medicinal herbs and Oldenlandia diffusa in particular. Int J Immunopharmacol. 1997; 19(7): 359-70.
31. Tiralongo E, Wee SS, Lea RA. Elderberry supplementation reduces cold duration and symptoms in air-travellers: a randomized, double-blind placebocontrolled clinical trial. Nutrients, 2016; 8(4): 182.
32. Ghosh A, Arora B, Gupta R, Anoop S, Misra A. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes Metab Syndr. 2020; 14(5): 917-20.
33. Pietrobelli A, Pecoraro L, Ferruzzi A, Heo M, Faith M, Zoller T, et al. Effects of COVID‐ 19 lockdown on lifestyle behaviors in children with obesity living in Verona, Italy: a longitudinal study. Obesity. 2020; 28(8): 1382-5.
34. Király O, Potenza MN, Stein DJ, King DL, Hodgins DC, Saunders JB, et al. Preventing problematic internet use during the COVID-19 pandemic: Consensus guidance. Compr Psychiatry. 2020; 100: 152180.
35. Testino G. Are patients with alcohol use disorders at increased risk for COVID-19 infection?. Alcohol Alcohol Suppl. 2020; 55(4): 344-6.
36. Dubey MJ, Ghosh R, Chatterjee S, Biswas P, Chatterjee S, Dubey S. COVID-19 and addiction. Diabetes Metab Syndr. 2020; 14: 817-23.
37. Varma RP. Alcohol withdrawal management during the Covid-19 lockdown in Kerala. Indian J Med Ethics. 2020; 2: 105-6.